Cargando…

Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data

We present Beyondcell, a computational methodology for identifying tumour cell subpopulations with distinct drug responses in single-cell RNA-seq data and proposing cancer-specific treatments. Our method calculates an enrichment score in a collection of drug signatures, delineating therapeutic clust...

Descripción completa

Detalles Bibliográficos
Autores principales: Fustero-Torre, Coral, Jiménez-Santos, María José, García-Martín, Santiago, Carretero-Puche, Carlos, García-Jimeno, Luis, Ivanchuk, Vadym, Di Domenico, Tomás, Gómez-López, Gonzalo, Al-Shahrour, Fátima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675493/
https://www.ncbi.nlm.nih.gov/pubmed/34911571
http://dx.doi.org/10.1186/s13073-021-01001-x
_version_ 1784615881387540480
author Fustero-Torre, Coral
Jiménez-Santos, María José
García-Martín, Santiago
Carretero-Puche, Carlos
García-Jimeno, Luis
Ivanchuk, Vadym
Di Domenico, Tomás
Gómez-López, Gonzalo
Al-Shahrour, Fátima
author_facet Fustero-Torre, Coral
Jiménez-Santos, María José
García-Martín, Santiago
Carretero-Puche, Carlos
García-Jimeno, Luis
Ivanchuk, Vadym
Di Domenico, Tomás
Gómez-López, Gonzalo
Al-Shahrour, Fátima
author_sort Fustero-Torre, Coral
collection PubMed
description We present Beyondcell, a computational methodology for identifying tumour cell subpopulations with distinct drug responses in single-cell RNA-seq data and proposing cancer-specific treatments. Our method calculates an enrichment score in a collection of drug signatures, delineating therapeutic clusters (TCs) within cellular populations. Additionally, Beyondcell determines the therapeutic differences among cell populations and generates a prioritised sensitivity-based ranking in order to guide drug selection. We performed Beyondcell analysis in five single-cell datasets and demonstrated that TCs can be exploited to target malignant cells both in cancer cell lines and tumour patients. Beyondcell is available at: https://gitlab.com/bu_cnio/beyondcell. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-021-01001-x.
format Online
Article
Text
id pubmed-8675493
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86754932021-12-20 Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data Fustero-Torre, Coral Jiménez-Santos, María José García-Martín, Santiago Carretero-Puche, Carlos García-Jimeno, Luis Ivanchuk, Vadym Di Domenico, Tomás Gómez-López, Gonzalo Al-Shahrour, Fátima Genome Med Method We present Beyondcell, a computational methodology for identifying tumour cell subpopulations with distinct drug responses in single-cell RNA-seq data and proposing cancer-specific treatments. Our method calculates an enrichment score in a collection of drug signatures, delineating therapeutic clusters (TCs) within cellular populations. Additionally, Beyondcell determines the therapeutic differences among cell populations and generates a prioritised sensitivity-based ranking in order to guide drug selection. We performed Beyondcell analysis in five single-cell datasets and demonstrated that TCs can be exploited to target malignant cells both in cancer cell lines and tumour patients. Beyondcell is available at: https://gitlab.com/bu_cnio/beyondcell. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-021-01001-x. BioMed Central 2021-12-16 /pmc/articles/PMC8675493/ /pubmed/34911571 http://dx.doi.org/10.1186/s13073-021-01001-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Method
Fustero-Torre, Coral
Jiménez-Santos, María José
García-Martín, Santiago
Carretero-Puche, Carlos
García-Jimeno, Luis
Ivanchuk, Vadym
Di Domenico, Tomás
Gómez-López, Gonzalo
Al-Shahrour, Fátima
Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data
title Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data
title_full Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data
title_fullStr Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data
title_full_unstemmed Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data
title_short Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data
title_sort beyondcell: targeting cancer therapeutic heterogeneity in single-cell rna-seq data
topic Method
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675493/
https://www.ncbi.nlm.nih.gov/pubmed/34911571
http://dx.doi.org/10.1186/s13073-021-01001-x
work_keys_str_mv AT fusterotorrecoral beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata
AT jimenezsantosmariajose beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata
AT garciamartinsantiago beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata
AT carreteropuchecarlos beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata
AT garciajimenoluis beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata
AT ivanchukvadym beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata
AT didomenicotomas beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata
AT gomezlopezgonzalo beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata
AT alshahrourfatima beyondcelltargetingcancertherapeuticheterogeneityinsinglecellrnaseqdata